Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)

China · Delayed Price · Currency is CNY

4.840

-0.080 (-1.63%)

May 20, 2026, 1:25 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Industrial		2.99B	2.46B	2.29B	2.86B	2.55B
Industrial Growth		21.18%	7.57%	-19.97%	12.14%	10.69%
Commercial Business		1.45B	1.69B	1.16B	162.38M	472.15M
Commercial Business Growth		-14.31%	45.33%	617.36%	-65.61%	-1.23%
Medical Institutions		64.22M	60.08M	51.78M	57.39M	38.09M
Medical Institutions Growth		6.90%	16.01%	-9.77%	50.66%	-28.09%
Others		36.31M	45.43M	32.37M	28.40M	24.73M
Others Growth		-20.07%	40.36%	13.97%	14.83%	221.08%
Intersegment Elimination		-712.27M	-	-	-	-
Total		3.83B	4.26B	3.54B	3.11B	3.09B
Total Growth		-10.26%	20.42%	13.79%	0.75%	8.32%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China		3.83B	4.26B	3.54B	3.11B	3.09B
China Growth		-10.26%	20.42%	13.79%	0.75%	8.32%
Total		3.83B	4.26B	3.54B	3.11B	3.09B
Total Growth		-10.26%	20.42%	13.79%	0.75%	8.32%

Source: S&P Global Market Intelligence.